Wednesday, May 01, 2024

Events | 2020.05.18

Global HIV Prevention Study Ends Early After Injectable Cabotegravir Shows High Efficacy

Cabotegravir was found to be 69% more effective in preventing HIV acquisition in men who have sex with men (MSM) and transgender women who have sex with men when compared to the current standard of care

(PRWeb May 18, 2020)

Read the full story at https://www.prweb.com/releases/global_hiv_prevention_study_ends_early_after_injectable_cabotegravir_shows_high_efficacy/prweb17130708.htm

 

For more information, please visit
https://www.prweb.com/releases/global_hi[...]igh_efficacy/prweb17130708.htm

You need to login to post comments.

Feed last updated 2024/04/30 @5:04 AM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News